Initial results from the Phase I study of MSC-1, a humanized anti-LIF monoclonal antibody, in patients with advanced solid tumors

被引：0

作者：

Schram, Alison ^{[1
]}

Spreafico, Anna ^{[2
]}

Oliva, Marc ^{[2
]}

Brana, Irene ^{[3
]}

Garralda, Elena ^{[3
]}

Lakhani, Nehal ^{[4
]}

Von Hoff, Daniel ^{[5
]}

Borazanci, Erkut ^{[5
]}

Pandya, Naimish ^{[6
]}

Hoffman, Kimberly ^{[6
]}

Hallett, Robin ^{[6
]}

Giblin, Patricia ^{[6
]}

Anido, Judit ^{[6
]}

Kelly, Adrianne ^{[6
]}

Wasserman, Robert ^{[6
]}

Seoane, Joan ^{[3
]}

Siu, Lillian ^{[2
]}

Hyman, David M. ^{[1
]}

Tabernero, Josep ^{[3
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[2] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada

[3] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Barcelona, Spain

[4] START Midwest, Grand Rapids, MI USA

[5] Honor Hlth, Scottsdale, AZ USA

[6] Northern Biol, Toronto, ON, Canada

来源：

CANCER RESEARCH | 2019年 / 79卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2019-CT014

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CT014

引用

页数：2

共 50 条

[41] A phase I study of nelmastobart (hSTC810), an anti-BTN1A1 antibody, in patients with advanced solid tumors
Lee, Soohyeon
Shin, Sangjoon
LoRusso, Patricia
Rolfo, Christian Diego
Jung, Hyunjin
Yoo, Stephen Sunghan
Hong, David S.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[42] PHASE I STUDY OF ANTI PD-1 ANTIBODY ONO-4538 IN JAPANESE PATIENTS WITH ADVANCED SOLID TUMORS
Yamamoto, N.
Nokihara, H.
Yamada, Y.
Asahina, H.
Shibata, T.
Tamura, Y.
Seki, Y.
Honda, K.
Tanabe, Y.
Wakui, H.
Tamura, T.
ANNALS OF ONCOLOGY, 2012, 23 : 26 - 26
[43] Phase I study of anti-PD-L1 antibody MPDL3280A in patients with advanced solid tumors
Murakami, Haruyasu
Yamamoto, Noboru
Kenmotsu, Hirotsugu
Takahashi, Toshiaki
Fujiwara, Yutaka
Mizugaki, Hidenori
Ishida, Yoshimasa
Kawakami, Tomohisa
ANNALS OF ONCOLOGY, 2015, 26 : 98 - 98
[44] Phase I study of the anti-PD-1 antibody SHR-1210 in patients with advanced solid tumors.
Huang, Jing
Mo, Hongnan
Wu, Dawei
Chen, Xuelian
Ma, Lanying
Lan, Bo
Qu, Dong
Yang, Qing
Xu, Binghe
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[45] Phase I study of pucotenlimab (HX008), an anti-PD-1 antibody, for patients with advanced solid tumors
Liu, Rujiao
Li, Wenhua
Meng, Yanchun
Gao, Shuiping
Zhang, Jian
Hu, Xichun
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
[46] Phase 1 study of MEDI0562, a humanized OX40 agonist monoclonal antibody (mAb), in adult patients (pts) with advanced solid tumors
Glisson, B. S.
Leidner, R.
Ferris, R. L.
Powderly, J.
Rizvi, N.
Norton, J. D.
Burton, J.
Lanasa, M. C.
Patel, S. P.
ANNALS OF ONCOLOGY, 2016, 27
[47] Phase 1 study of anti-epidermal growth factor receptor monoclonal antibody in patients with solid tumors
Wang, Chong
He, Xiaohui
Zhou, Bo
Li, Jing
Li, Bohua
Qian, Weizhu
Hou, Sheng
Wang, Hao
Shi, Yuankai
Guo, Yajun
MABS, 2011, 3 (01) : 67 - 75
[48] A phase I study of sonepcizumab (S), a humanized monocional antibody to sphingosine-1-phosphate (S1P), in patients with advanced solid tumors
Gordan, M. S.
Just, R.
Rosen, L. S.
Dorr, A.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[49] Population Pharmacokinetic Analysis From Phase I and Phase II Studies of the Humanized Monovalent Antibody, Onartuzumab (MetMAb), in Patients With Advanced Solid Tumors
Xin, Yan
Jin, Denise
Eppler, Stephen
Damico-Beyer, Lisa A.
Joshi, Amita
Davis, John D.
Kaur, Surinder
Nijem, Ihsan
Bothos, John
Peterson, Amy
Patel, Premal
Bai, Shuang
JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (11): : 1103 - 1111
[50] Docetaxel and ifosfamide in patients with advanced solid tumors: Results of a phase I study
Pronk, LC
Schrijvers, D
Schellens, JHM
de Bruijn, EA
Planting, AST
Locci-Tonelli, D
Groult, V
Verweij, J
van Oosterom, AT
SEMINARS IN ONCOLOGY, 1998, 25 (01) : 23 - 28

← 1 2 3 4 5 →